Serotonin (5-Hydroxytryptamine) · Serotonin (5HT) receptors Mechanism of action Receptor subtype...
Transcript of Serotonin (5-Hydroxytryptamine) · Serotonin (5HT) receptors Mechanism of action Receptor subtype...
• Serotonin is one of autacoids
• In human:
• 90% of serotonin presents in the enterocromaffin cells in the intestine,
• 8% presents in platelets,
• 2% in CNS.
Biosynthesis:
L-tryptophan hydroxylase L-tryptophan 5-hydroxytryptophan
Aromatic L-amino acid decarboxylase
5-hydroxytryptamine (serotonin)
Serotonin (5HT) receptors
Mechanism of
action
Distribution Receptor subtype
Decrease cAMP Raphe
nuclei,hippocampus 5-HT1A
Decrease cAMP Substansia nigra,
basal ganglia 5-HT1B
Decrease cAMP Cortex, putamin 5-HT1D
Decrease cAMP Cortex,
hyppocampus 5-HT1E
Decrease cAMP Enteric nervous
system 5-HT1F
Mechanism of action Distribution Receptor subtype
Increase IP3 Platelets, smooth
muscle, cerebral
cortex, skeletal muscle
5-HT2A
Increase IP3 Stomach 5-HT2B
Increase IP3 Hippocampus,
substansia nigra 5-HT2C
Na+, K+ ion
channel
Enteric system 5-HT3
Increase cAMP CNS, smooth muscle 5-HT4
Decrease cAMP Brain 5-HT5
Increase cAMP Brain 5-HT6,7
• Pharmacological actions
• Nervous system:
• 5-HT3 receptors in the GIT and in vomiting center in the medulla play a role in vomiting center.
• Activation of 5-HT3 receptor on vagal nerve ending causes bradycardia and hypotension.
• Serotonin, like histamine, is a potent stimulant of pain and itch sensory ending.
3-Cardiovascular system
• Serotonin causes contraction of vascular smooth muscle, through 5-HT2 receptors.
• Serotonin is a powerful vesoconstrictor except in skeletal muscle and heart where it dilate blood vessels.
• It can also, causes reflex bradycardia by activation of 5-HT3 receptors on chemoreceptor nerve endings.
• A triphasic blood pressure response is seen following injection of serotonin in experimental animals:
• Initially, there is a decrease in heart rate, cardiac output, and blood pressure caused by the chemoreceptor response.
• After this decrease, blood pressure increases as a result of vasoconstriction.
• The third phase is again a decrease in blood pressure attributed to vasodilation in vessels supplying skeletal muscle.
4- Gastrointestinal tract
• is a powerful stimulant of gastrointestinal smooth muscle, increasing tone and facilitating peristalsis. This action is caused by the direct action of serotonin on 5-HT 2 smooth muscle receptors..
5. Skeletal muscle
• 5 -HT2 receptors are present on skeletal muscle membranes, but their physiologic role is not understood.
Serotonin syndrome :
• It is a condition associated with restlessness, hyperthermia and skeletal muscle contractions. It is precipitated when MAO inhibitors are given with serotonin agonists, especially antidepressants of the selective serotonin reuptake inhibitor class.
Serotonin Agonists Serotonin has no clinical applications as a drug. Buspirone: a 5-HT1A agonist, is a
nonbenzodiazepine anxiolytic. Triptans Triptans ( eg, sumatriptan ), 5-HT ?? agonists,
are used for migraine headache.
Cisapride, a 5-HT 4 agonist, was used in the treatment of gastroesophageal reflux and motility disorders.
Tegaserod, a 5-HT 4 partial agonist, is used for irritable bowel syndrome with constipation.
Fluoxetine and other selective serotonin reuptake inhibitors (SSRIs), block reuptake of serotonin. It is used for treatment of depression.
SEROTONIN-RECEPTOR ANTAGONISTS Phenoxybenzamine blocks 5-HT 2 receptors. Ergot alkaloids are partial agonists at serotonin
receptors. Cyproheptadine blocks H 1 –receptor and 5-HT 2
actions. The actions of cyproheptadine:
• antimuscarinic effects • sedation. • treatment of carcinoid tumor • urticaria. • appetite stimulant.
Ketanserin blocks:
• 5-HT 2 receptors on smooth muscle and platelets
• vascular α 1 adrenoceptors.
• The drug:
• inhibits platelet aggregation promoted by serotonin.
• decreases blood pressure
Ritanserin, another 5-HT 2 antagonist, has little or no α-blocking
Ondansetron:
• It is 5-HT 3 antagonist.
• It is very important in the prevention and treatment of nausea and vomiting associated with surgery and cancer therapy.
Ergot alkaloids
• Ergot alkaloids are produced by Claviceps purpurea , a fungus that infects grasses and grains—especially rye—under damp growing or storage conditions.
• This fungus synthesizes histamine, acetylcholine, tyramine, and other biologically active products in addition to ergot alkaloids.
• These alkaloids affect α adrenoceptors, dopamine receptors, 5-HT receptors, and perhaps other receptor types
Organ System Effects
1-Central nervous system
Lysergic acid diethylamide (LSD) is a synthetic, 5-HT 2 antagonis, powerful hallucinogens.
• It has no clinical value.
• Abuse of this drug is widespread.
Bromocriptine suppresses prolactin secretion from pituitary cells by activating dopamine receptors.
•
2- Vascular smooth muscle
• Ergotamine and similar compounds constrict most vessels.
3- Uterine smooth muscle
• In very small doses, ergot preparations can evoke rhythmic contraction and relaxation of the uterus.
• At higher concentrations, these drugs induce powerful and prolonged contracture.
4- Other smooth muscle organs
• Ergot alkaloids have little or no significant effect on bronchiolar or urinary smooth muscle.
• Ergot s cause nausea, vomiting, and diarrhea even by low doses in some patients.
Clinical Uses
A. Migraine:
Ergot derivatives are specific for migraine pain. Such as:
Ergotamine tartrate It is often combined with caffeine.
Dihydroergotamine .
B. Hyperprolactinemia: Bromocriptine is used to r treatment of hyperprolactinemia.
C. Postpartum Hemorrhage: • Oxytocin is the preferred agent for control of
postpartum hemorrhage, but if this agent is ineffective, ergonovine maleate given intramuscularly.
• Ergot derivatives should be used only for control of postpartum uterine bleeding and should never be given before delivery.
• Types of migraine headaches:
• migraine without aura ( called common migraine)
• migraine with aura ( called classic migraine), the headache is preceded by visual, sensory, and/or cause speech or motor disturbances.
• Migraine may be due to extracranial and intracranial arterial dilation. This stretching leads to release of neuroactive molecules, such as substance P.
Symptomatic (nonspecific) treatment of acute migraine
• Nonsteroidal anti-inflammatory drugs such as aspirin, indomethacine
• antiemetics, such as metoclopromide, prochlorperazine, to control vomiting.
• Opioids
• β-adrenoceptor blockers : such as Propranolol
• calcium channel blockers : such as verapamil
• tricyclic antidepressants: such as amitriptyline
• several antiseizure agents.
Specific treatment of migraine
1- Triptans:
This class of drugs includes:
sumatriptan ,
naratriptan ,
rizatriptan,
eletriptan ,
almotriptan ,
frovatriptan
zolmitriptan
• The triptans are serotonin agonists( type of receptor ?? ), acting at serotonin receptors found on peripheral nerves that innervate the intracranial vasculature.
• Triptans causes less nausea than dihydroergotamine .
• Adverse effects are elevation of blood pressure. Therefore, triptans should not be used in coronary artery disease .